Results 261 to 270 of about 74,318 (299)

Introduction to the reviews on neuropeptide Y

Neuropeptides, 2004
Neuropeptide Y (NPY) was first reported as an abundant peptide in brain tissue in 1982. Shortly thereafter, NPY was found to be a member of a peptide family consisting of the endocrine peptides pancreatic polypeptide (PP) and peptide YY (PYY). These peptides exert most of their biological effects through five G-protein coupled receptors termed Y1, Y2 ...
openaire   +2 more sources

Neuropeptide Y

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
openaire   +4 more sources

[Neuropeptide Y].

Nihon rinsho. Japanese journal of clinical medicine, 2000
Y, Kawakami, T, Nakai
openaire   +3 more sources

Neuropeptide Y has a stimulatory action on feeding behavior in goldfish (Carassius auratus)

European Journal of Pharmacology, 1999
Marcos A López-Patiño, Ana Guijarro, Esther Isorna   +2 more
exaly  

Neuropeptide Y

2007
C CARVAJAL, Y DUMONT, R QUIRION
openaire   +2 more sources

GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists

European Journal of Pharmacology, 1998
Eric M Parker, A Balasubramaniam, Robert E Burrier   +2 more
exaly  

Effect of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246 on neuropeptide Y release

European Journal of Pharmacology, 2000
Peter S Widdowson
exaly  

Neuropeptide Y

1986
Satya P. Kalra, L. G. Allen, J. T. Clark, W. R. Crowley, P. S. Kalra   +4 more
openaire   +1 more source

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226

European Journal of Pharmacology, 1994
Klaus Rudolf, Wolfgang Eberlein, Heike A Wieland   +2 more
exaly  

Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status

European Journal of Pharmacology, 2002
Andrew Stamford
exaly